
    
      AIMS To assess the effectiveness of EarlyCDT-Lung test in increasing early stage lung cancer
      detection, thereby reducing the rate of late stage (3 / 4 / U) presentation, compared to
      normal clinical practice; to assess the cost-effectiveness of EarlyCDT-Lung test compared to
      normal clinical practice; to assess the effectiveness of EarlyCDT-Lung test in reducing
      adverse outcomes including potential psychological and behavioural consequences.
    
  